Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.25 million versus the consensus estimate of $9.48 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

Earnings